메뉴 건너뛰기




Volumn 4, Issue 2, 2012, Pages 153-181

IBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of the Antibody Society, December 5-8, 2011, San Diego, CA

Author keywords

[No Author keywords available]

Indexed keywords

AVP 02; AVP 04; BEVACIZUMAB; CARBOPLATIN; CYCLOPHOSPHAMIDE; ETANERCEPT; IMGN 529; IMGN 853; INFLUENZA VACCINE; INTERLEUKIN 2; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2F5; MONOCLONAL ANTIBODY 2G12; MONOCLONAL ANTIBODY 4E10; MONOCLONAL ANTIBODY B12; MONOCLONAL ANTIBODY HAPP1; MONOCLONAL ANTIBODY IMC 1C11; MONOCLONAL ANTIBODY SAP; MONOCLONAL ANTIBODY VL12.3; MONOCLONAL ANTIBODY XMAB55; MOTAVIZUMAB; OFATUMUMAB; PACLITAXEL; PALIVIZUMAB; RAMUCIRUMAB; RANIBIZUMAB; RESPIRATORY SYNCYTIAL VIRUS VACCINE; RITUXIMAB; TANIBIRUMAB; TRASTUZUMAB; TTAC 0001; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 84858231336     PISSN: 19420862     EISSN: 19420870     Source Type: Journal    
DOI: 10.4161/mabs.4.2.19495     Document Type: Conference Paper
Times cited : (3)

References (11)
  • 1
    • 80052740269 scopus 로고    scopus 로고
    • In vitro and in vivo responses of advanced prostate tumors to PSMA ADC, an auristatin-conjugated antibody to prostate-specific membrane antigen
    • PMID:21750220
    • Wang X, Ma D, Olson WC, Heston WD. In vitro and in vivo responses of advanced prostate tumors to PSMA ADC, an auristatin-conjugated antibody to prostate-specific membrane antigen. Mol Cancer Ther 2011; 10:1728-39; PMID:21750220; http://dx.doi.org/10.1158/1535-7163.MCT-11-0191.
    • (2011) Mol Cancer Ther , vol.10 , pp. 1728-1739
    • Wang, X.1    Ma, D.2    Olson, W.C.3    Heston, W.D.4
  • 2
    • 0028927442 scopus 로고
    • nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts
    • PMID:7814155
    • Weterman MA, Ajubi N, van Dinter IM, Degen WG, van Muijen GN, Ruitter DJ, et al. nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts. Int J Cancer 1995; 60:73-81; PMID:7814155; http://dx.doi.org/10.1002/ijc.2910600111.
    • (1995) Int J Cancer , vol.60 , pp. 73-81
    • Weterman, M.A.1    Ajubi, N.2    Van Dinter, I.M.3    Degen, W.G.4    Van Muijen, G.N.5    Ruitter, D.J.6
  • 3
    • 33644747384 scopus 로고    scopus 로고
    • CR011, a fully human monoclonal antibody-auristatin e conjugate, for the treatment of melanoma
    • PMID:16489096
    • Tse KF, Jeffers M, Pollack VA, McCabe DA, Shadish ML, Khramtsov NV, et al. CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma. Clin Cancer Res 2006; 12:1373-82; PMID:16489096; http://dx.doi.org/10.1158/1078-0432.CCR-05-2018.
    • (2006) Clin Cancer Res , vol.12 , pp. 1373-1382
    • Tse, K.F.1    Jeffers, M.2    Pollack, V.A.3    McCabe, D.A.4    Shadish, M.L.5    Khramtsov, N.V.6
  • 4
    • 79952646477 scopus 로고    scopus 로고
    • Frequent dosing and GPNMB expression with CDX-011 (CR011-vcMMAE), an antibody-drug conjugate (ADC), in patients with advanced melanoma
    • ASCO Annual Meeting Abstract 8525
    • Hamid O, Sznol M, Pavlick AC, Kluger HM, Kim KB, Boasberg PD, et al. Frequent dosing and GPNMB expression with CDX-011 (CR011-vcMMAE), an antibody-drug conjugate (ADC), in patients with advanced melanoma. J Clin Oncol 2010; 28; ASCO Annual Meeting Abstract 8525.
    • (2010) J Clin Oncol , vol.28
    • Hamid, O.1    Sznol, M.2    Pavlick, A.C.3    Kluger, H.M.4    Kim, K.B.5    Boasberg, P.D.6
  • 5
    • 84858205260 scopus 로고    scopus 로고
    • Correlation of GPNMB expression with outcome in breast cancer (BC) patients treated with the antibody-drug conjugate (ADC), CDX-011 (CR011-vcMMAE)
    • ASCO Annual Meeting Abstract 1095
    • Saleh MN, Bendell JC, Rose A, Siegel P, Hart LL, Sirpal S, et al. Correlation of GPNMB expression with outcome in breast cancer (BC) patients treated with the antibody-drug conjugate (ADC), CDX-011 (CR011-vcMMAE). J Clin Oncol 2010; 28; ASCO Annual Meeting Abstract 1095.
    • (2010) J Clin Oncol , vol.28
    • Saleh, M.N.1    Bendell, J.C.2    Rose, A.3    Siegel, P.4    Hart, L.L.5    Sirpal, S.6
  • 6
    • 84863116661 scopus 로고    scopus 로고
    • Therapeutic mechanism and efficacy of the antibody drug-conjugate BAY 79-4620 targeting human carbonic anhydrase 9
    • PMID:22147747
    • Petrul HM, Schatz CA, Kopitz CC, Adnane L, McCabe TJ, Trail PA, et al. Therapeutic mechanism and efficacy of the antibody drug-conjugate BAY 79-4620 targeting human carbonic anhydrase 9. Mol Cancer Ther 2012; 11:340-9; PMID:22147747; http://dx.doi.org/10.1158/1535-7163.MCT-11-0523.
    • (2012) Mol Cancer Ther , vol.11 , pp. 340-349
    • Petrul, H.M.1    Schatz, C.A.2    Kopitz, C.C.3    Adnane, L.4    McCabe, T.J.5    Trail, P.A.6
  • 7
    • 79955658810 scopus 로고    scopus 로고
    • Rational engineering of antibody therapeutics targeting multiple oncogene pathways
    • PMID:21393992
    • Fitzgerald J, Lugovskoy A. Rational engineering of antibody therapeutics targeting multiple oncogene pathways. MAbs 2011; 3:299-309; PMID:21393992; http://dx.doi.org/10.4161/mabs.3.3.15299.
    • (2011) MAbs , vol.3 , pp. 299-309
    • Fitzgerald, J.1    Lugovskoy, A.2
  • 8
    • 84855401857 scopus 로고    scopus 로고
    • Building and characterizing antibody-targeted lipidic nanotherapeutics
    • PMID:22208985
    • Kirpotin DB, Noble CO, Hayes ME, Huang Z, Kornaga T, Zhou Y, et al. Building and characterizing antibody-targeted lipidic nanotherapeutics. Methods Enzymol 2012; 502:139-66; PMID:22208985; http://dx.doi.org/10.1016/B978-0-12- 416039-2.00007-0.
    • (2012) Methods Enzymol , vol.502 , pp. 139-166
    • Kirpotin, D.B.1    Noble, C.O.2    Hayes, M.E.3    Huang, Z.4    Kornaga, T.5    Zhou, Y.6
  • 9
    • 35948977323 scopus 로고    scopus 로고
    • Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin
    • PMID:17934452
    • Wu C, Ying H, Grinnell C, Bryant S, Miller R, Clabbers A, et al. Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin. Nat Biotechnol 2007; 25:1290-7; PMID:17934452; http://dx.doi.org/10.1038/nbt1345.
    • (2007) Nat Biotechnol , vol.25 , pp. 1290-1297
    • Wu, C.1    Ying, H.2    Grinnell, C.3    Bryant, S.4    Miller, R.5    Clabbers, A.6
  • 10
    • 84855366636 scopus 로고    scopus 로고
    • Generation of dual-variable-domain immunoglobulin molecules for dual-specific targeting
    • PMID:22208980
    • Gu J, Ghayur T. Generation of dual-variable-domain immunoglobulin molecules for dual-specific targeting. Methods Enzymol 2012; 502:25-41; PMID:22208980; http://dx.doi.org/10.1016/B978-0-12-416039-2.00002-1.
    • (2012) Methods Enzymol , vol.502 , pp. 25-41
    • Gu, J.1    Ghayur, T.2
  • 11
    • 77951520735 scopus 로고    scopus 로고
    • Molecular construction and optimization of anti-human IL-1alpha/beta dual variable domain immunoglobulin (DVD-Ig) molecules
    • PMID:20068402
    • Wu C, Ying H, Bose S, Miller R, Medina L, Santora L, et al. Molecular construction and optimization of anti-human IL-1alpha/beta dual variable domain immunoglobulin (DVD-Ig) molecules. MAbs 2009; 1:339-47; PMID:20068402; http://dx.doi.org/10.4161/mabs.1.4.8755.
    • (2009) MAbs , vol.1 , pp. 339-347
    • Wu, C.1    Ying, H.2    Bose, S.3    Miller, R.4    Medina, L.5    Santora, L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.